7AZN

Structure of mouse AsterC (GramD1c) with a new cholesterol-derived compound

7AZN の概要

• エントリーDOI: 10.2210/pdb7azn/pdb
• 関連するPDBエントリー: 6gqf
• 分子名称: Protein Aster-C, 20alpha-hydroxy-20-(5-methylhexyl)cholesterol, ETHANOL, ... (5 entities in total)
• 機能のキーワード: non vesicular cholesterol transport, lipid-binding, endoplasmic reticulum, membrane contact sites, lipid transport
• 由来する生物種: Mus musculus (Mouse)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 21618.87

構造登録者

Romartinez-Alonso, B.,Sirvydis, K.,Kim, Y.,Xiao, X.,Jung, M.,Tontonoz, P.,Schwabe, J. (登録日: 2020-11-16, 公開日: 2021-01-13, 最終更新日: 2024-01-31)

主引用文献

Xiao, X.,Kim, Y.,Romartinez-Alonso, B.,Sirvydis, K.,Ory, D.S.,Schwabe, J.W.R.,Jung, M.E.,Tontonoz, P.
Selective Aster inhibitors distinguish vesicular and nonvesicular sterol transport mechanisms.
Proc.Natl.Acad.Sci.USA, 118:-, 2021

PubMed Abstract: The Aster proteins (encoded by the genes) contain a ligand-binding fold structurally similar to a START domain and mediate nonvesicular plasma membrane (PM) to endoplasmic reticulum (ER) cholesterol transport. In an effort to develop small molecule modulators of Asters, we identified 20α-hydroxycholesterol (HC) and U18666A as lead compounds. Unfortunately, both 20α-HC and U18666A target other sterol homeostatic proteins, limiting their utility. 20α-HC inhibits sterol regulatory element-binding protein 2 (SREBP2) processing, and U18666A is an inhibitor of the vesicular trafficking protein Niemann-Pick C1 (NPC1). To develop potent and selective Aster inhibitors, we synthesized a series of compounds by modifying 20α-HC and U18666A. Among these, AI (Aster inhibitor)-1l, which has a longer side chain than 20α-HC, selectively bound to Aster-C. The crystal structure of Aster-C in complex with AI-1l suggests that sequence and flexibility differences in the loop that gates the binding cavity may account for the ligand specificity for Aster C. We further identified the U18666A analog AI-3d as a potent inhibitor of all three Aster proteins. AI-3d blocks the ability of Asters to bind and transfer cholesterol in vitro and in cells. Importantly, AI-3d also inhibits the movement of low-density lipoprotein (LDL) cholesterol to the ER, although AI-3d does not block NPC1. This finding positions the nonvesicular Aster pathway downstream of NPC1-dependent vesicular transport in the movement of LDL cholesterol to the ER. Selective Aster inhibitors represent useful chemical tools to distinguish vesicular and nonvesicular sterol transport mechanisms in mammalian cells.

PubMed: 33376205
DOI: 10.1073/pnas.2024149118

実験手法

X-RAY DIFFRACTION (2.09 Å)